How do you make evidence-based decisions when there is no evidence?

August 13, 2019 Latest News

This is a preview of subscriber content

Subscribe now to continue reading.

Australia's traditional approach to HTA has relied on decisions based on large amounts of data and evidence at the time of initial funding evaluation - something that simply will not be available in the era of personalised medicine. …

Subscribe now to continue reading.

Latest Video

Georgia Forrest

Budget update repeats the 'fiscal illusion' that has become PBS spending
December 17, 2025 - Latest News
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - Latest News
Novartis names new Country President following leadership transition
December 16, 2025 - Latest News
Budget update includes impact of listings, but generally not much else
December 16, 2025 - Latest News
The UK reconfirms the direct impact of the transatlantic shift in medicine pricing
December 16, 2025 - Latest News

How do you make evidence-based decisions when there is no evidence?

This is a preview of subscriber content

Latest Video

Most Read

Budget update repeats the 'fiscal illusion' that has become PBS spending

The industry is probably right to resist, it just needs to prepare for the response

Novartis names new Country President following leadership transition

Budget update includes impact of listings, but generally not much else

The UK reconfirms the direct impact of the transatlantic shift in medicine pricing

New Stories

Priceline moves to stabilise banner group as pressures force administrators

Rare Cancers Australia gearing up for 2026 Kosi Challenge with Pharma Cup up for grabs again

Ferronova secures funding to advance nanoparticle technology for cancer surgery

Antimalarial candidate under WEHI-MSD partnership offers fresh hope against resistance

OncoSil completes first production run at new Sydney manufacturing facility

Budget update repeats the 'fiscal illusion' that has become PBS spending

Island Pharmaceuticals secures key partnership with Texas Biomed

Sign In

How do you make evidence-based decisions when there is no evidence?

This is a preview of subscriber content

Latest Video

Most Read

Budget update repeats the 'fiscal illusion' that has become PBS spending

The industry is probably right to resist, it just needs to prepare for the response

Novartis names new Country President following leadership transition

Budget update includes impact of listings, but generally not much else

The UK reconfirms the direct impact of the transatlantic shift in medicine pricing

Follow Us

New Stories

Priceline moves to stabilise banner group as pressures force administrators

Rare Cancers Australia gearing up for 2026 Kosi Challenge with Pharma Cup up for grabs again

Ferronova secures funding to advance nanoparticle technology for cancer surgery

Antimalarial candidate under WEHI-MSD partnership offers fresh hope against resistance

OncoSil completes first production run at new Sydney manufacturing facility

Budget update repeats the 'fiscal illusion' that has become PBS spending

Island Pharmaceuticals secures key partnership with Texas Biomed